The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| HCAT | -63.38% | -90.85% | -38.01% | -92% |
| S&P | +14.5% | +93.32% | +14.09% | +123% |
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.
The data analytics specialist delivered results that weren't as bad as investors had feared.
These companies are raining down revenue from cloud computing.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $80.72M | 6.3% |
| Gross Profit | $25.79M | 1.5% |
| Gross Margin | 31.95% | -1.5% |
| Market Cap | $262.40M | -30.4% |
| Market Cap / Employee | $0.17M | 0.0% |
| Employees | 1.5K | 15.4% |
| Net Income | -$40.98M | -203.2% |
| EBITDA | $1.02M | 170.7% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $50.71M | -74.9% |
| Accounts Receivable | $68.38M | 24.6% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $167.28M | 911.4% |
| Short Term Debt | $5.51M | -97.6% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -15.31% | -3.1% |
| Return On Invested Capital | -19.71% | 2.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$14.19M | -482.8% |
| Operating Free Cash Flow | -$9.00M | -658.1% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 1.40 | 1.21 | 0.79 | 0.70 | -34.08% |
| Price to Sales | 1.63 | 1.44 | 1.00 | 0.83 | -34.37% |
| Price to Tangible Book Value | 11.21 | 9.74 | 14.96 | -6.10 | -262.37% |
| Enterprise Value to EBITDA | -211.58 | -155.56 | -293.46 | 330.99 | -249.66% |
| Return on Equity | -21.5% | -19.0% | -19.8% | -28.4% | 22.77% |
| Total Debt | $364.33M | $402.27M | $402.37M | $172.79M | -30.51% |
HCAT earnings call for the period ending June 30, 2022.
HCAT earnings call for the period ending March 31, 2022.
HCAT earnings call for the period ending December 31, 2021.
HCAT earnings call for the period ending September 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
